Companies: 10,795·Total market cap: $144.5T
Korro Bio, Inc.

Korro Bio, Inc.

KRRONASDAQHealthcare● Active
$10.59
$-0.13(-1.21%)
Market Cap$105406157
P/E Ratio
52W High$55.89
52W Low$5.204
Overview

Korro Bio, Inc.(KRRO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · KRRO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$6.39M$2.27M$0.00M$0.00M$14.07M
Cost of Revenue$4.28M$0.00M$0.00M$0.00M$3.84M
Gross Profit$2.11M$2.27M$0.00M$0.00M$10.23M
Gross Margin %(computed)33.04%100.00%72.70%
Operating Expenses
R&D Expenses$65.58M$63.64M$57.25M$42.20M$59.32M
G&A Expenses$28.16M$30.55M$24.03M$16.80M$0.00M
Total Operating Expenses$89.45M$94.18M$84.53M$59.00M$94.26M
Operating Income($87.34M)($91.91M)($84.53M)($59.00M)($84.03M)
Operating Margin %(computed)-597.32%
Interest Income$0.00M$0.00M$0.00M$0.95M$0.40M
Interest Expense$0.00M$0.00M$0.00M$0.12M$0.76M
Income Before Tax($116.62M)($83.44M)($81.14M)($58.02M)($84.67M)
Income Tax Expense$0.64M$0.14M$0.03M$0.01M$0.01M
Net Income($117.26M)($83.58M)($81.17M)($58.03M)($84.69M)
Net Margin %(computed)-601.98%
Per Share & EBITDA
EPS (Basic)$-12.48$-9.37$-53.09$-227.58$-4.94
Wtd Avg Shares9.40M8.92M1.53M0.26M4.45M
EBITDA($83.06M)($88.34M)($80.90M)($56.49M)($80.07M)
EBITDA Margin %(computed)-569.14%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Korro Bio, Inc.

关于Korro Bio, Inc.(KRRO)损益表

Korro Bio, Inc.(KRRO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,KRRO实现营收$0.01B,毛利润$0.00B(毛利率33.04%),净利润($0.12B)(净利率-1834.48%)。

常见问题

KRRO · 4 问

Korro Bio, Inc.(KRRO)2025财年营收为$0.01B,同比up181.5%。

KRRO revenueKRRO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09